Happiest Minds Technologies / Q4-FY25

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2025-04-22Back to HAPPSTMNDS

Revenue

₹545 Cr

verified against source

Revenue YoY

26.4%

reported change

EBITDA

₹462 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
10 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 103 · Positive source sentiment · 2023-07-20Q1 FY24Q2 FY24: 105 · Watch source sentiment · 2023-10-20Q2 FY24Q3 FY24: 105 · Watch source sentiment · 2024-01-17Q3 FY24Q4 FY24: 108 · Positive source sentiment · 2024-05-07Q4 FY24Q1 FY25: 117 · Positive source sentiment · 2024-07-20Q1 FY25Q2 FY25: 119 · Positive source sentiment · 2024-10-22Q2 FY25Q3 FY25: 117 · Positive source sentiment · 2025-01-22Q3 FY25Q4 FY25: 462 · Positive source sentiment · 2025-04-22Q4 FY25Q1 FY26: 124 · Positive source sentiment · 2025-07-24Q1 FY26Q3 FY26: 123 · Positive source sentiment · 2026-01-28Q3 FY26462103
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Happiest Minds delivered a strong FY25 with constant currency revenue growth of 25.6%, reaching $244M and crossing the INR 2,000 crore threshold. Q4 constant currency growth was 1.1% QoQ and 27.9% YoY, impacted by a $1.5M bad debt provision from a U.S. government client. EBITDA margin for the year was 21.4%, within the guided 20%-22% range, despite ~INR 40 crore investments in GenAI and new sales. Management guided for healthy double-digit organic growth in FY26 and FY27, driven by 10 transformational initiatives including vertical reorganization, a dedicated GenAI business unit, and a new healthcare product expected by Q1 FY27. Key risks include delayed decision-making in manufacturing/retail and potential dilution from M&A earn-outs. The company remains confident in its growth trajectory despite industry headwinds.

Colored figures show movement against the previous available record.

Guidance to track

  • Management expects organic growth to remain in double digits for the next two years, driven by transformational initiatives.
  • The company reiterated its EBITDA margin range of 20%-22% for the foreseeable future.
  • A revolutionary healthcare product based on bioinformatics is expected to be available for launch by Q1 FY27, with cash-positive operations from the first year.
  • A new integrated structure combining Happiest Minds, PureSoftware, and Aureus will be announced within 4-6 weeks.

Risks flagged

  • A customer with U.S. government business reneged on payment, causing a $1.5M provision and revenue loss in Q4.
  • Delayed decision-making and a wait-and-watch approach by clients in manufacturing and retail sectors pose a risk to growth.
  • The higher edtech segment is challenged due to enrollment drops and cost pressures, requiring a pivot to workforce development.
  • Better-than-expected performance of acquired entities leads to additional earn-out payments that hit the P&L as exceptional items.

Key quotes

  • We want to state emphatically that at Happiest Minds, we see no recession-driven slowdowns.
  • Our investments are beginning to show immense progress and performance, and outcomes of these are wired into our growth plan for FY 2026 and forward.
  • The goal will remain the same, but we'll evaluate this in detail during the course of the next quarter. If not by the next quarter, by October, we will restate where we stand on that goal.

Research modules

Go one layer deeper.